|
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
262 results found
| no | title | author | magazine | year | volume | issue | page(s) | type |
| 1 | Accrediting for screening-related colonoscopy services: What is required of the endoscopist and of the endoscopy service? |
Wieten, Els |
2016 |
48-49 | 3 |
p. 487-495 9 p. |
article |
|
| 2 | Acquiring and maintaining competency in gastrointestinal endoscopy |
Dubé, Catherine |
2016 |
48-49 | 3 |
p. 339-347 9 p. |
article |
|
| 3 | Adaptive diagnosis of coeliac disease |
Korponay-Szabó, Ilma R. |
2015 |
48-49 | 3 |
p. 381-398 18 p. |
article |
|
| 4 | Advances in modern enteroscopy therapeutics |
Kaffes, Arthur John |
2012 |
48-49 | 3 |
p. 235-246 12 p. |
article |
|
| 5 | Aims & Scope/Editorial Board |
2009 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 6 | Aims & Scope/ Editorial Board |
2014 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 7 | Aims & scope/editorial board |
2006 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 8 | Aims & scope/editorial board |
2007 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 9 | Aims & Scope/ Editorial Board |
2010 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 10 | Aims ; scope/editorial board |
2005 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 11 | Aims & scope/editorial board |
2008 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 12 | Aims & Scope/ Editorial Board |
2017 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 13 | Aims & Scope/ Editorial Board |
2015 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 14 | Aims & Scope/ Editorial Board |
2016 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 15 | Aims & Scope/ Editorial Board |
2011 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 16 | Aims & Scope/ Editorial Board |
2013 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 17 | Aims & Scope/ Editorial Board |
2012 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 18 | Alteration in digestion and absorption of nutrients during profound acid suppression |
Evenepoel, Pieter |
2001 |
48-49 | 3 |
p. 539-551 13 p. |
article |
|
| 19 | Alterations in intragastric nitrite and vitamin C levels during acid inhibitory therapy |
Mowat, Craig |
2001 |
48-49 | 3 |
p. 523-537 15 p. |
article |
|
| 20 | Altered anatomy: Enteroscopy and ERCP procedure |
Moreels, Tom G. |
2012 |
48-49 | 3 |
p. 347-357 11 p. |
article |
|
| 21 | Animal models of HBV infection |
Dandri, Maura |
2017 |
48-49 | 3 |
p. 273-279 7 p. |
article |
|
| 22 | Approach to the patient with presumed extraoesophageal GERD |
Ates, Fehmi |
2013 |
48-49 | 3 |
p. 415-431 17 p. |
article |
|
| 23 | Assessments and skills improvement for endoscopists |
Anderson, John T. |
2016 |
48-49 | 3 |
p. 453-471 19 p. |
article |
|
| 24 | Audit and feedback interventions to improve endoscopist performance: Principles and effectiveness |
Tinmouth, Jill |
2016 |
48-49 | 3 |
p. 473-485 13 p. |
article |
|
| 25 | Bacterial translocation in the gut |
Wiest, Reiner |
2003 |
48-49 | 3 |
p. 397-425 29 p. |
article |
|
| 26 | Biliary sludge and cholecystitis |
Ko, Cynthia W |
2003 |
48-49 | 3 |
p. 383-396 14 p. |
article |
|
| 27 | Bones in coeliac disease: diagnosis and treatment |
Corazza, Gino Roberto |
2005 |
48-49 | 3 |
p. 453-465 13 p. |
article |
|
| 28 | Can we get more from our current treatments? |
Irving, Peter M. |
2014 |
48-49 | 3 |
p. 451-463 13 p. |
article |
|
| 29 | Case-finding in coeliac disease should be intensified |
Mulder, Chris J.J. |
2005 |
48-49 | 3 |
p. 479-486 8 p. |
article |
|
| 30 | Celiac disease from a global perspective |
Lionetti, Elena |
2015 |
48-49 | 3 |
p. 365-379 15 p. |
article |
|
| 31 | Cholestasis of sepsis |
Gilroy, Richard K |
2003 |
48-49 | 3 |
p. 357-367 11 p. |
article |
|
| 32 | Classification of eosinophilic gastrointestinal diseases |
Mueller, Susanna |
2008 |
48-49 | 3 |
p. 425-440 16 p. |
article |
|
| 33 | Clinical relevance of autoimmune-related pancreatitis |
Okazaki, Kazuichi |
2002 |
48-49 | 3 |
p. 365-378 14 p. |
article |
|
| 34 | Clostridium difficile infection and pseudomembranous colitis |
Wilcox, Mark H |
2003 |
48-49 | 3 |
p. 475-493 19 p. |
article |
|
| 35 | Coeliac disease: changing views |
Mulder, C.J.J. |
2005 |
48-49 | 3 |
p. 313-321 9 p. |
article |
|
| 36 | Coeliac disease in children |
Fasano, Alessio |
2005 |
48-49 | 3 |
p. 467-478 12 p. |
article |
|
| 37 | Coeliac disease in developing countries: Middle East, India and North Africa |
Malekzadeh, Reza |
2005 |
48-49 | 3 |
p. 351-358 8 p. |
article |
|
| 38 | Coeliac disease: is it time for mass screening? |
Mearin, M. Luisa |
2005 |
48-49 | 3 |
p. 441-452 12 p. |
article |
|
| 39 | Combination therapies for the endoscopic treatment of gastrointestinal bleeding |
Hiele, Martin |
2000 |
48-49 | 3 |
p. 459-466 8 p. |
article |
|
| 40 | Complications of coeliac disease |
Malamut, Georgia |
2015 |
48-49 | 3 |
p. 451-458 8 p. |
article |
|
| 41 | Complications of gastro-oesophageal reflux disease |
Parasa, S. |
2013 |
48-49 | 3 |
p. 433-442 10 p. |
article |
|
| 42 | Current indications for acid suppressants in dyspepsia |
Bytzer, Peter |
2001 |
48-49 | 3 |
p. 385-400 16 p. |
article |
|
| 43 | Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease |
Howden, Colin W. |
2001 |
48-49 | 3 |
p. 401-412 12 p. |
article |
|
| 44 | Current role of acid suppressants in Helicobacter pylori eradication therapy |
Labenz, Joachim |
2001 |
48-49 | 3 |
p. 413-431 19 p. |
article |
|
| 45 | Current status of endoscopic therapy for ulcer bleeding |
Rollhauser, C. |
2000 |
48-49 | 3 |
p. 391-410 20 p. |
article |
|
| 46 | Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon |
Ghany, Marc G. |
2017 |
48-49 | 3 |
p. 299-309 11 p. |
article |
|
| 47 | Cystic fibrosis and related diseases of the pancreas |
Naruse, Satoru |
2002 |
48-49 | 3 |
p. 511-526 16 p. |
article |
|
| 48 | Cystic fibrosis: Nutritional consequences and management |
Dodge, John A. |
2006 |
48-49 | 3 |
p. 531-546 16 p. |
article |
|
| 49 | Development of quality measures for monitoring and improving care in gastroenterology |
Germansky, Katharine A. |
2011 |
48-49 | 3 |
p. 387-395 9 p. |
article |
|
| 50 | Diagnosis of chronic pancreatitis: Functional testing |
Domínguez Muñoz, J. Enrique |
2010 |
48-49 | 3 |
p. 233-241 9 p. |
article |
|
| 51 | Diagnosis of coeliac disease |
Green, Peter H.R. |
2005 |
48-49 | 3 |
p. 389-400 12 p. |
article |
|
| 52 | Diagnostic imaging in Crohn's disease: What is the new gold standard? |
Dambha, F. |
2014 |
48-49 | 3 |
p. 421-436 16 p. |
article |
|
| 53 | Disorders of intestinal secretion and absorption |
Schulzke, Jörg-Dieter |
2009 |
48-49 | 3 |
p. 395-406 12 p. |
article |
|
| 54 | Disturbances in large bowel motility |
Spiller, Robin C |
1999 |
48-49 | 3 |
p. 397-413 17 p. |
article |
|
| 55 | Disturbances in small bowel motility |
Quigley, Eamonn M.M. |
1999 |
48-49 | 3 |
p. 385-395 11 p. |
article |
|
| 56 | Double- vs. single-balloon vs. spiral enteroscopy |
Lenz, Philipp |
2012 |
48-49 | 3 |
p. 303-313 11 p. |
article |
|
| 57 | Drug treatment for bleeding oesophageal varices |
Dagher, Lucy |
2000 |
48-49 | 3 |
p. 365-390 26 p. |
article |
|
| 58 | Drug treatment of non-variceal upper gastrointestinal bleeding |
Langman, M.J.S. |
2000 |
48-49 | 3 |
p. 357-364 8 p. |
article |
|
| 59 | Editorial Board |
2003 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 60 | Editorial Board |
2004 |
48-49 | 3 |
p. iii- 1 p. |
article |
||
| 61 | Emerging therapeutic options in GERD |
Woodland, Philip |
2013 |
48-49 | 3 |
p. 455-467 13 p. |
article |
|
| 62 | Endoscopic approaches to enteral nutritional support |
DiSario, James A. |
2006 |
48-49 | 3 |
p. 605-630 26 p. |
article |
|
| 63 | Endoscopic treatment in chronic pancreatitis, timing, duration and type of intervention |
Nguyen-Tang, Thai |
2010 |
48-49 | 3 |
p. 281-298 18 p. |
article |
|
| 64 | Enteral and parenteral nutrition in acute pancreatitis |
Imrie, Clement W. |
2002 |
48-49 | 3 |
p. 391-397 7 p. |
article |
|
| 65 | Enteroscopy: Advances in diagnostic imaging |
Mönkemüller, Klaus |
2012 |
48-49 | 3 |
p. 221-233 13 p. |
article |
|
| 66 | Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses |
Ekbom, Anders |
2004 |
48-49 | 3 |
p. 497-508 12 p. |
article |
|
| 67 | Eosinophilia during intestinal infection |
Löscher, Thomas |
2008 |
48-49 | 3 |
p. 511-536 26 p. |
article |
|
| 68 | Eosinophils and allergic diseases of the gastrointestinal tract |
Bischoff, Stephan C. |
2008 |
48-49 | 3 |
p. 455-479 25 p. |
article |
|
| 69 | Epidemiology of hepatitis B and the role of vaccination |
Chang, Matthew S. |
2017 |
48-49 | 3 |
p. 239-247 9 p. |
article |
|
| 70 | Epidemiology of IBD during the twentieth century: an integrated view |
Binder, Vibeke |
2004 |
48-49 | 3 |
p. 463-479 17 p. |
article |
|
| 71 | Epidemiology of inflammatory bowel disease: Focus on Asia |
Ng, Siew C. |
2014 |
48-49 | 3 |
p. 363-372 10 p. |
article |
|
| 72 | Epidemiology of reflux symptoms and GORD |
Ronkainen, Jukka |
2013 |
48-49 | 3 |
p. 325-337 13 p. |
article |
|
| 73 | ERCP and MRCP – when and why |
Albert, J.G. |
2002 |
48-49 | 3 |
p. 399-419 21 p. |
article |
|
| 74 | EUS in the diagnosis of early-stage chronic pancreatitis |
Hernandez, Lyndon V. |
2010 |
48-49 | 3 |
p. 243-249 7 p. |
article |
|
| 75 | Exploring & exploiting our ‘other self’ – Does the microbiota hold the key to the future therapy in Crohn's? |
Haag, Lea-Maxie |
2014 |
48-49 | 3 |
p. 399-409 11 p. |
article |
|
| 76 | Fate of nerves in chronic pancreatitis: Neural remodeling and pancreatic neuropathy |
Ceyhan, Güralp O. |
2010 |
48-49 | 3 |
p. 311-322 12 p. |
article |
|
| 77 | Food allergies and food intolerances |
Ortolani, Claudio |
2006 |
48-49 | 3 |
p. 467-483 17 p. |
article |
|
| 78 | Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency |
DiMagno, Eugene P. |
2001 |
48-49 | 3 |
p. 477-486 10 p. |
article |
|
| 79 | Gastric mucosal morphological consequences of acid suppression: a balanced view |
Meuwissen, S.G.M. |
2001 |
48-49 | 3 |
p. 497-510 14 p. |
article |
|
| 80 | Gastroesophageal reflux disease: Current state-of-the-art management |
Reimer, Christina |
2013 |
48-49 | 3 |
p. 323- 1 p. |
article |
|
| 81 | Gastrointestinal motility testing |
Smout, André J.P.M. |
2009 |
48-49 | 3 |
p. 287-298 12 p. |
article |
|
| 82 | General laboratory diagnostics of eosinophilic GI diseases |
Conus, Sébastien |
2008 |
48-49 | 3 |
p. 441-453 13 p. |
article |
|
| 83 | Genetic basis of pancreatic cancer |
Schmid, Roland M. |
2002 |
48-49 | 3 |
p. 421-433 13 p. |
article |
|
| 84 | Genetic factors in chronic pancreatitis; implications for diagnosis, management and prognosis |
Derikx, Monique H.M. |
2010 |
48-49 | 3 |
p. 251-270 20 p. |
article |
|
| 85 | Genetics in coeliac disease |
van Heel, David A. |
2005 |
48-49 | 3 |
p. 323-339 17 p. |
article |
|
| 86 | Genetics of celiac disease |
Ricaño-Ponce, Isis |
2015 |
48-49 | 3 |
p. 399-412 14 p. |
article |
|
| 87 | Genetic studies of Crohn's disease: Past, present and future |
Liu, Jimmy Z. |
2014 |
48-49 | 3 |
p. 373-386 14 p. |
article |
|
| 88 | Genome scan analyses and positional cloning strategy in IBD: successes and limitations |
Wild, Gary E |
2004 |
48-49 | 3 |
p. 541-553 13 p. |
article |
|
| 89 | Gluten-free diet—what is toxic? |
Ciclitira, Paul J. |
2005 |
48-49 | 3 |
p. 359-371 13 p. |
article |
|
| 90 | Harnessing the patient’s powers of recovery: the role of the psychotherapies in the irritable bowel syndrome |
Read, Nicholas W. |
1999 |
48-49 | 3 |
p. 473-487 15 p. |
article |
|
| 91 | Hepatitis B virus infection |
Janssen, Harry L.A. |
2017 |
48-49 | 3 |
p. 237- 1 p. |
article |
|
| 92 | Hepatitis B virus infection and the immune response: The big questions |
Boeijen, Lauke L. |
2017 |
48-49 | 3 |
p. 265-272 8 p. |
article |
|
| 93 | Hepatitis delta infection – Current and new treatment options |
Elazar, Menashe |
2017 |
48-49 | 3 |
p. 321-327 7 p. |
article |
|
| 94 | Hereditary pancreatitis: a model for inflammatory diseases of the pancreas |
Schneider, Alexander |
2002 |
48-49 | 3 |
p. 347-363 17 p. |
article |
|
| 95 | Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease |
Katz, Philip O. |
2001 |
48-49 | 3 |
p. 371-384 14 p. |
article |
|
| 96 | How reflux causes symptoms: Reflux perception in gastroesophageal reflux disease |
Weijenborg, Pim W. |
2013 |
48-49 | 3 |
p. 353-364 12 p. |
article |
|
| 97 | How will insights from genetics translate to clinical practice in inflammatory bowel disease? |
Festen, E.A.M. |
2014 |
48-49 | 3 |
p. 387-397 11 p. |
article |
|
| 98 | IBD: a family affair |
Russell, R.K |
2004 |
48-49 | 3 |
p. 525-539 15 p. |
article |
|
| 99 | Idiopathic eosinophilic disorders of the gastrointestinal tract in children |
Mukkada, Vincent A. |
2008 |
48-49 | 3 |
p. 497-509 13 p. |
article |
|
| 100 | Idiopathic eosinophilic gastrointestinal diseases in adults |
Straumann, Alex |
2008 |
48-49 | 3 |
p. 481-496 16 p. |
article |
|
| 101 | Immunisations in Crohn's disease: Who? Why? What? When? |
Magro, F. |
2014 |
48-49 | 3 |
p. 485-496 12 p. |
article |
|
| 102 | Improving the outcome of fistulising Crohn's disease |
Molendijk, Ilse |
2014 |
48-49 | 3 |
p. 505-518 14 p. |
article |
|
| 103 | Index |
2003 |
48-49 | 3 |
p. I-III nvt p. |
article |
||
| 104 | Index |
1999 |
48-49 | 3 |
p. 505-509 5 p. |
article |
||
| 105 | Index |
2000 |
48-49 | 3 |
p. I1-I8 nvt p. |
article |
||
| 106 | Index |
2001 |
48-49 | 3 |
p. I1-I3 nvt p. |
article |
||
| 107 | Inflammatory bowel disease: a complex group of genetic disorders |
Hugot, Jean-Pierre |
2004 |
48-49 | 3 |
p. 451-462 12 p. |
article |
|
| 108 | Inflammatory bowel disease: causes and consequences |
Hugot, Jean-Pierre |
2004 |
48-49 | 3 |
p. 447-449 3 p. |
article |
|
| 109 | Injection therapy for endoscopic haemostasis |
Church, N.I. |
2000 |
48-49 | 3 |
p. 427-441 15 p. |
article |
|
| 110 | Innate immunity: Actuating the gears of celiac disease pathogenesis |
Kim, Sangman Michael |
2015 |
48-49 | 3 |
p. 425-435 11 p. |
article |
|
| 111 | Insights from immunology: New targets for new drugs? |
Raine, Tim |
2014 |
48-49 | 3 |
p. 411-420 10 p. |
article |
|
| 112 | Intestinal and anorectal motility and functional disorders |
Keller, Jutta |
2009 |
48-49 | 3 |
p. 407-423 17 p. |
article |
|
| 113 | Intraepithelial lymphocytes and coeliac disease |
Collin, Pekka |
2005 |
48-49 | 3 |
p. 341-350 10 p. |
article |
|
| 114 | In-training gastrointestinal endoscopy competency assessment tools: Types of tools, validation and impact |
Walsh, Catharine M. |
2016 |
48-49 | 3 |
p. 357-374 18 p. |
article |
|
| 115 | Irritable bowel syndrome: a management strategy |
Thompson, W.Grant |
1999 |
48-49 | 3 |
p. 453-460 8 p. |
article |
|
| 116 | Irritable bowel syndrome: definition, diagnosis and epidemiology |
Talley, Nicholas J. |
1999 |
48-49 | 3 |
p. 371-384 14 p. |
article |
|
| 117 | Irritable bowel syndrome: making sense of it all |
Phillips, Sidney F. |
1999 |
48-49 | 3 |
p. 489-503 15 p. |
article |
|
| 118 | Irritable bowel syndrome: new pharmaceutical approaches to treatment |
Farthing, Michael J.G. |
1999 |
48-49 | 3 |
p. 461-471 11 p. |
article |
|
| 119 | Leadership and team building in gastrointestinal endoscopy |
Valori, Roland M. |
2016 |
48-49 | 3 |
p. 497-509 13 p. |
article |
|
| 120 | Learning curve for endoscopy training: Is it all about numbers? |
Forbes, Nauzer |
2016 |
48-49 | 3 |
p. 349-356 8 p. |
article |
|
| 121 | Malignant complications of coeliac disease |
Brousse, N. |
2005 |
48-49 | 3 |
p. 401-412 12 p. |
article |
|
| 122 | Malnutrition: Etiology, consequences, and assessment of a patient at risk |
Alberda, Cathy |
2006 |
48-49 | 3 |
p. 419-439 21 p. |
article |
|
| 123 | Management of hepatitis B in special populations |
Zhou, Kali |
2017 |
48-49 | 3 |
p. 311-320 10 p. |
article |
|
| 124 | Management of reflux-related symptoms |
Dutta, Usha |
2013 |
48-49 | 3 |
p. 387-400 14 p. |
article |
|
| 125 | Management of the patient with incomplete response to PPI therapy |
Kahrilas, Peter J. |
2013 |
48-49 | 3 |
p. 401-414 14 p. |
article |
|
| 126 | Mandatory and optional function tests for biliary disorders |
Dauer, Marc |
2009 |
48-49 | 3 |
p. 441-451 11 p. |
article |
|
| 127 | Mandatory and optional function tests in gastroduodenal disorders |
Tack, J. |
2009 |
48-49 | 3 |
p. 387-393 7 p. |
article |
|
| 128 | Measures of trainee performance in advanced endoscopy: A systematic review |
James, P.D. |
2016 |
48-49 | 3 |
p. 421-452 32 p. |
article |
|
| 129 | Mechanical endoscopic methods of haemostasis for bleeding peptic ulcers: a review |
Hepworth, Clive C. |
2000 |
48-49 | 3 |
p. 467-476 10 p. |
article |
|
| 130 | Mechanics of quality assurance – Now and in the future |
Aabakken, Lars |
2011 |
48-49 | 3 |
p. 419-425 7 p. |
article |
|
| 131 | Mechanism and prediction of HCC development in HBV infection |
Xu, Weiqi |
2017 |
48-49 | 3 |
p. 291-298 8 p. |
article |
|
| 132 | Medico-legal aspects and concerns in quality assurance in the United States |
Saxton, James W. |
2011 |
48-49 | 3 |
p. 409-417 9 p. |
article |
|
| 133 | Meetings announcement |
2005 |
48-49 | 3 |
p. 487- 1 p. |
article |
||
| 134 | Methods and functions: Breath tests |
Braden, Barbara |
2009 |
48-49 | 3 |
p. 337-352 16 p. |
article |
|
| 135 | Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants |
Lin, Chih-Lin |
2017 |
48-49 | 3 |
p. 249-255 7 p. |
article |
|
| 136 | New insulins in the treatment of diabetes mellitus |
Lindholm, Anders |
2002 |
48-49 | 3 |
p. 475-492 18 p. |
article |
|
| 137 | New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies |
Gehring, Adam J. |
2017 |
48-49 | 3 |
p. 337-345 9 p. |
article |
|
| 138 | New treatments to reach functional cure: Virological approaches |
Durantel, David |
2017 |
48-49 | 3 |
p. 329-336 8 p. |
article |
|
| 139 | NOD2/CARD15: relevance in clinical practice |
Vermeire, Severine |
2004 |
48-49 | 3 |
p. 569-575 7 p. |
article |
|
| 140 | Non-celiac gluten sensitivity: A work-in-progress entity in the spectrum of wheat-related disorders |
Volta, Umberto |
2015 |
48-49 | 3 |
p. 477-491 15 p. |
article |
|
| 141 | Non-celiac wheat sensitivity: Differential diagnosis, triggers and implications |
Schuppan, Detlef |
2015 |
48-49 | 3 |
p. 469-476 8 p. |
article |
|
| 142 | Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis |
Denzer, Ulrike W. |
2009 |
48-49 | 3 |
p. 453-460 8 p. |
article |
|
| 143 | Non-occlusive mesenteric ischaemia: a common disorder in gastroenterology and intensive care |
Kolkman, Jeroen J |
2003 |
48-49 | 3 |
p. 457-473 17 p. |
article |
|
| 144 | Not all monoclonals are created equal – Lessons from failed drug trials in Crohn's disease |
Kaser, Arthur |
2014 |
48-49 | 3 |
p. 437-449 13 p. |
article |
|
| 145 | Novel developments in Crohn's disease |
Janneke van der Woude, C. |
2014 |
48-49 | 3 |
p. 361- 1 p. |
article |
|
| 146 | Nutritional care of the patient with constipation |
Fernández-Bañares, Fernando |
2006 |
48-49 | 3 |
p. 575-587 13 p. |
article |
|
| 147 | Nutrition and motility disorders |
Karamanolis, G. |
2006 |
48-49 | 3 |
p. 485-505 21 p. |
article |
|
| 148 | Nutrition in end stage liver disease |
Kondrup, Jens |
2006 |
48-49 | 3 |
p. 547-560 14 p. |
article |
|
| 149 | Nutrition in inflammatory bowel disease |
O'Sullivan, Maria |
2006 |
48-49 | 3 |
p. 561-573 13 p. |
article |
|
| 150 | Nutrition in pancreatic diseases |
Meier, Rémy F. |
2006 |
48-49 | 3 |
p. 507-529 23 p. |
article |
|
| 151 | Nutrition in the prevention of gastrointestinal cancer |
van den Brandt, Piet A. |
2006 |
48-49 | 3 |
p. 589-603 15 p. |
article |
|
| 152 | Occurrence and significance of gastric colonization during acid-inhibitory therapy |
Williams, Craig |
2001 |
48-49 | 3 |
p. 511-521 11 p. |
article |
|
| 153 | Origin, regulation and physiological function of intestinal oeosinophils |
Fulkerson, Patricia C. |
2008 |
48-49 | 3 |
p. 411-423 13 p. |
article |
|
| 154 | Overview of the quality assurance movement in health care |
de Jonge, Vincent |
2011 |
48-49 | 3 |
p. 337-347 11 p. |
article |
|
| 155 | Pain management in chronic pancreatitis: A treatment algorithm |
Chauhan, Shailendra |
2010 |
48-49 | 3 |
p. 323-335 13 p. |
article |
|
| 156 | Pancreas and islet cell transplantation |
Bottino, Rita |
2002 |
48-49 | 3 |
p. 457-474 18 p. |
article |
|
| 157 | Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection |
Raimondi, Sara |
2010 |
48-49 | 3 |
p. 349-358 10 p. |
article |
|
| 158 | Pancreatic enzyme replacement therapy in chronic pancreatitis |
Sikkens, E.C.M. |
2010 |
48-49 | 3 |
p. 337-347 11 p. |
article |
|
| 159 | Pancreatic sepsis: prevention and therapy |
Gloor, Beat |
2002 |
48-49 | 3 |
p. 379-390 12 p. |
article |
|
| 160 | Pathomechanisms in celiac disease |
Koning, Frits |
2005 |
48-49 | 3 |
p. 373-387 15 p. |
article |
|
| 161 | Pathophysiology of gastroesophageal reflux disease |
Lee, Yeong Yeh |
2013 |
48-49 | 3 |
p. 339-351 13 p. |
article |
|
| 162 | Pharmacogenetics of inflammatory bowel disease☆ |
Mascheretti, Silvia |
2004 |
48-49 | 3 |
p. 597-609 13 p. |
article |
|
| 163 | Pharmacological and pharmacodynamic essentials of H2-receptor antagonists and proton pump inhibitors for the practising physician |
Huang, Jia-Qing |
2001 |
48-49 | 3 |
p. 355-370 16 p. |
article |
|
| 164 | Preface |
Layer, P. |
2009 |
48-49 | 3 |
p. 285-286 2 p. |
article |
|
| 165 | Preface |
Schölmerich, J. |
2003 |
48-49 | 3 |
p. 325- 1 p. |
article |
|
| 166 | Preface |
Houghton, Lesley A. |
1999 |
48-49 | 3 |
p. vii- 1 p. |
article |
|
| 167 | Preface |
Mathus-Vliegen, Elisabeth M.H. |
2006 |
48-49 | 3 |
p. 417- 1 p. |
article |
|
| 168 | Preface |
Tack, J. |
2007 |
48-49 | 3 |
p. 363- 1 p. |
article |
|
| 169 | Preface |
Bruno, Marco |
2010 |
48-49 | 3 |
p. 217- 1 p. |
article |
|
| 170 | Preface |
Mulder, Chris |
2005 |
48-49 | 3 |
p. 311- 1 p. |
article |
|
| 171 | Preface |
Bischoff, Stephan C. |
2008 |
48-49 | 3 |
p. 389- 1 p. |
article |
|
| 172 | Preface |
2002 |
48-49 | 3 |
p. vii- 1 p. |
article |
||
| 173 | Preface |
Koning, Frits |
2015 |
48-49 | 3 |
p. 363- 1 p. |
article |
|
| 174 | Preface |
K.E.L. McColl, |
2001 |
48-49 | 3 |
p. vii- 1 p. |
article |
|
| 175 | Preface |
2000 |
48-49 | 3 |
p. vii- 1 p. |
article |
||
| 176 | Preventing complications in celiac disease: Our experience with managing adult celiac disease |
Mulder, C.J. |
2015 |
48-49 | 3 |
p. 459-468 10 p. |
article |
|
| 177 | Problems related to acid rebound and tachyphylaxis |
Gillen, Derek |
2001 |
48-49 | 3 |
p. 487-495 9 p. |
article |
|
| 178 | Pseudo-obstruction in the critically ill |
Delgado-Aros, Silvia |
2003 |
48-49 | 3 |
p. 427-444 18 p. |
article |
|
| 179 | Putative inflammatory and immunological mechanisms in functional bowel disorders |
Collins, Stephen M. |
1999 |
48-49 | 3 |
p. 429-436 8 p. |
article |
|
| 180 | Quality assurance for endoscopists |
Petersen, Bret T. |
2011 |
48-49 | 3 |
p. 349-360 12 p. |
article |
|
| 181 | Quality assurance in endoscopy nursing |
Beilenhoff, Ulrike |
2011 |
48-49 | 3 |
p. 371-385 15 p. |
article |
|
| 182 | Quality assurance in gastroenterology |
Cotton, Peter B. |
2011 |
48-49 | 3 |
p. 335-336 2 p. |
article |
|
| 183 | Quality assurance in gastroenterology: QA in research, and research in QA |
Hoff, Geir |
2011 |
48-49 | 3 |
p. 427-434 8 p. |
article |
|
| 184 | Quality assurance in perioperative care |
Hoeks, Sanne E. |
2011 |
48-49 | 3 |
p. 435-441 7 p. |
article |
|
| 185 | Quality assurance of endoscopy units |
Stebbing, John F. |
2011 |
48-49 | 3 |
p. 361-370 10 p. |
article |
|
| 186 | Quality assurance of training |
Dunckley, Paul |
2011 |
48-49 | 3 |
p. 397-407 11 p. |
article |
|
| 187 | Reflux monitoring: pH-metry, Bilitec and Oesophageal impedance measurements |
Pohl, Daniel |
2009 |
48-49 | 3 |
p. 299-311 13 p. |
article |
|
| 188 | Refractory coeliac disease |
Daum, Severin |
2005 |
48-49 | 3 |
p. 413-424 12 p. |
article |
|
| 189 | Role of acid suppressants in intensive care medicine |
Tryba, Michael |
2001 |
48-49 | 3 |
p. 447-461 15 p. |
article |
|
| 190 | Role of acid suppressants in prophylaxis of NSAID damage |
Chan, Francis K.L. |
2001 |
48-49 | 3 |
p. 433-445 13 p. |
article |
|
| 191 | Role of enteral and parenteral nutrition in the patient with gastrointestinal and liver disease |
Stratton, Rebecca J. |
2006 |
48-49 | 3 |
p. 441-466 26 p. |
article |
|
| 192 | Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours |
Wedemeyer, Jochen |
2008 |
48-49 | 3 |
p. 537-549 13 p. |
article |
|
| 193 | Safety of long-term PPI therapy |
Reimer, Christina |
2013 |
48-49 | 3 |
p. 443-454 12 p. |
article |
|
| 194 | Secretion and absorption (methods and functions) |
Lankisch, Paul Georg |
2009 |
48-49 | 3 |
p. 325-335 11 p. |
article |
|
| 195 | Sensory dysfunction and the irritable bowel syndrome |
Houghton, Lesley A. |
1999 |
48-49 | 3 |
p. 415-427 13 p. |
article |
|
| 196 | Severe chronic abdominal pain in the absence of adhesions |
Thompson, David G. |
2007 |
48-49 | 3 |
p. 465-472 8 p. |
article |
|
| 197 | Shock and acute pancreatitis |
Isenmann, Rainer |
2003 |
48-49 | 3 |
p. 345-355 11 p. |
article |
|
| 198 | Shock liver |
Strassburg, Christian P |
2003 |
48-49 | 3 |
p. 369-381 13 p. |
article |
|
| 199 | Simulator training in gastrointestinal endoscopy – From basic training to advanced endoscopic procedures |
van der Wiel, S.E. |
2016 |
48-49 | 3 |
p. 375-387 13 p. |
article |
|
| 200 | Small bowel diagnostics: Current place of small bowel endoscopy |
Aktas, Huseyin |
2012 |
48-49 | 3 |
p. 209-220 12 p. |
article |
|
| 201 | Small bowel endoscopy |
Mensink, Peter B.F. |
2012 |
48-49 | 3 |
p. 207-208 2 p. |
article |
|
| 202 | Small bowel endoscopy and coeliac disease |
Daveson, A. James M. |
2012 |
48-49 | 3 |
p. 315-323 9 p. |
article |
|
| 203 | Small bowel endoscopy and Peutz-Jeghers syndrome |
Korsse, Susanne E. |
2012 |
48-49 | 3 |
p. 263-278 16 p. |
article |
|
| 204 | Small bowel endoscopy: Cost-effectiveness of the different approaches |
Gerson, Lauren B. |
2012 |
48-49 | 3 |
p. 325-335 11 p. |
article |
|
| 205 | Small bowel endoscopy for obscure GI bleeding |
Teshima, Christopher W. |
2012 |
48-49 | 3 |
p. 247-261 15 p. |
article |
|
| 206 | Small bowel endoscopy in children |
de Ridder, L. |
2012 |
48-49 | 3 |
p. 337-345 9 p. |
article |
|
| 207 | Small bowel endoscopy in familial adenomatous polyposis and Lynch syndrome |
Koornstra, Jan Jacob |
2012 |
48-49 | 3 |
p. 359-368 10 p. |
article |
|
| 208 | Small bowel endoscopy in inflammatory bowel disease |
Despott, Edward J. |
2012 |
48-49 | 3 |
p. 279-291 13 p. |
article |
|
| 209 | Sonographic assessments of gastrointestinal and biliary functions |
Dietrich, Christoph F. |
2009 |
48-49 | 3 |
p. 353-367 15 p. |
article |
|
| 210 | Specificities of inflammatory bowel disease in childhood |
Griffiths, Anne M. |
2004 |
48-49 | 3 |
p. 509-523 15 p. |
article |
|
| 211 | Spiral enteroscopy: Prime time or for the happy few? |
Akerman, Paul A. |
2012 |
48-49 | 3 |
p. 293-301 9 p. |
article |
|
| 212 | Stress-related mucosal disease in critically ill patients |
Duerksen, Donald R |
2003 |
48-49 | 3 |
p. 327-344 18 p. |
article |
|
| 213 | Surgery in the acute management of bleeding peptic ulcer |
Lau, James Y.W. |
2000 |
48-49 | 3 |
p. 505-518 14 p. |
article |
|
| 214 | Surgical and medical therapy for pancreatic carcinoma |
Magee, Conor J. |
2002 |
48-49 | 3 |
p. 435-455 21 p. |
article |
|
| 215 | Surgical treatment in chronic pancreatitis timing and type of procedure |
Bachmann, Kai |
2010 |
48-49 | 3 |
p. 299-310 12 p. |
article |
|
| 216 | Systemic consequences of ileus |
Madl, Christian |
2003 |
48-49 | 3 |
p. 445-456 12 p. |
article |
|
| 217 | T-cell and B-cell immunity in celiac disease |
du Pré, M. Fleur |
2015 |
48-49 | 3 |
p. 413-423 11 p. |
article |
|
| 218 | Tests of pancreatic exocrine function – Clinical significance in pancreatic and non-pancreatic disorders |
Keller, Jutta |
2009 |
48-49 | 3 |
p. 425-439 15 p. |
article |
|
| 219 | The biosimilar road in inflammatory bowel disease: The right way? |
Fiorino, Gionata |
2014 |
48-49 | 3 |
p. 465-471 7 p. |
article |
|
| 220 | The contribution of HLA genes to IBD susceptibility and phenotype |
Yap, Lee Min |
2004 |
48-49 | 3 |
p. 577-596 20 p. |
article |
|
| 221 | The difficult patient in gastroenterology: chronic pelvic pain, adhesions, and sub occlusive episodes |
Peters, A.A.W. |
2007 |
48-49 | 3 |
p. 445-463 19 p. |
article |
|
| 222 | The difficult patient with constipation |
Müller-Lissner, Stefan |
2007 |
48-49 | 3 |
p. 473-484 12 p. |
article |
|
| 223 | The difficult patient with gastroparesis |
Tack, Jan |
2007 |
48-49 | 3 |
p. 379-391 13 p. |
article |
|
| 224 | The epidemiology and socioeconomic impact of chronic pancreatitis |
Jupp, James |
2010 |
48-49 | 3 |
p. 219-231 13 p. |
article |
|
| 225 | The initial diagnosis of GERD |
Vakil, Nimish |
2013 |
48-49 | 3 |
p. 365-371 7 p. |
article |
|
| 226 | The mucosal immune system at the gastrointestinal barrier |
Schenk, Mirjam |
2008 |
48-49 | 3 |
p. 391-409 19 p. |
article |
|
| 227 | The natural history of adenomas |
Risio, Mauro |
2010 |
48-49 | 3 |
p. 271-280 10 p. |
article |
|
| 228 | The patient with GORD and chronically recurrent problems |
Smout, André J.P.M. |
2007 |
48-49 | 3 |
p. 365-378 14 p. |
article |
|
| 229 | The patient with multiple intestinal polyps |
Schulmann, Karsten |
2007 |
48-49 | 3 |
p. 409-426 18 p. |
article |
|
| 230 | The patient with persistent perianal fistulae |
Koutroubakis, Ioannis E. |
2007 |
48-49 | 3 |
p. 503-518 16 p. |
article |
|
| 231 | The patient with recidivent obscure gastrointestinal bleeding |
Heil, Ulrich |
2007 |
48-49 | 3 |
p. 393-407 15 p. |
article |
|
| 232 | The patient with recurrent (sub) obstruction due to Crohn's disease |
Lahat, Adi |
2007 |
48-49 | 3 |
p. 427-444 18 p. |
article |
|
| 233 | The patient with refractory ascites |
Gerbes, Alexander L. |
2007 |
48-49 | 3 |
p. 551-560 10 p. |
article |
|
| 234 | The patient with refractory diarrhoea |
Farthing, Michael J.G. |
2007 |
48-49 | 3 |
p. 485-501 17 p. |
article |
|
| 235 | The patient with slightly elevated pancreatic enzymes and abdominal complaints |
Keller, Jutta |
2007 |
48-49 | 3 |
p. 519-533 15 p. |
article |
|
| 236 | The patient with unexplained elevated serum liver enzymes |
Holstege, Axel |
2007 |
48-49 | 3 |
p. 535-550 16 p. |
article |
|
| 237 | The prevention of coeliac disease |
Mearin, M.Luisa |
2015 |
48-49 | 3 |
p. 493-501 9 p. |
article |
|
| 238 | Therapeutic approaches for celiac disease |
Plugis, Nicholas M. |
2015 |
48-49 | 3 |
p. 503-521 19 p. |
article |
|
| 239 | Thermal probes alone or with epinephrine for the endoscopic haemostasis of ulcer haemorrhage |
Machicado, Gustavo A. |
2000 |
48-49 | 3 |
p. 443-458 16 p. |
article |
|
| 240 | The role of acid suppressants in upper gastrointestinal ulcer bleeding |
van Leerdam, Monique E. |
2001 |
48-49 | 3 |
p. 463-475 13 p. |
article |
|
| 241 | The role of animal models in unravelling therapeutic targets in coeliac disease |
Costes, Léa M.M. |
2015 |
48-49 | 3 |
p. 437-450 14 p. |
article |
|
| 242 | The role of Doppler ultrasound in gastrointestinal bleeding |
Riemann, Jürgen F. |
2000 |
48-49 | 3 |
p. 495-504 10 p. |
article |
|
| 243 | The role of endoscopic therapy in the treatment of bleeding varices |
Bohnacker, Sabine |
2000 |
48-49 | 3 |
p. 477-494 18 p. |
article |
|
| 244 | The role of psychosocial factors in irritable bowel syndrome |
Gaynes, Bradley N. |
1999 |
48-49 | 3 |
p. 437-452 16 p. |
article |
|
| 245 | The surgical intervention: Earlier or never? |
Bemelman, W.A. |
2014 |
48-49 | 3 |
p. 497-503 7 p. |
article |
|
| 246 | The Swedish epidemic of coeliac disease explored using an epidemiological approach—some lessons to be learnt |
Ivarsson, Anneli |
2005 |
48-49 | 3 |
p. 425-440 16 p. |
article |
|
| 247 | The virological aspects of hepatitis B |
Valaydon, Zina S. |
2017 |
48-49 | 3 |
p. 257-264 8 p. |
article |
|
| 248 | Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice |
Cosnes, Jacques |
2004 |
48-49 | 3 |
p. 481-496 16 p. |
article |
|
| 249 | Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease |
Philpott, Dana J |
2004 |
48-49 | 3 |
p. 555-568 14 p. |
article |
|
| 250 | Training for advanced endoscopic procedures |
Feurer, Matthew E. |
2016 |
48-49 | 3 |
p. 397-408 12 p. |
article |
|
| 251 | Training in gastrointestinal endoscopy: Preface |
Dubé, Catherine |
2016 |
48-49 | 3 |
p. 337-338 2 p. |
article |
|
| 252 | Training non-physicians to do endoscopy: Feasibility, effectiveness and cost-effectiveness |
Ruco, A. |
2016 |
48-49 | 3 |
p. 389-396 8 p. |
article |
|
| 253 | Training the gastrointestinal endoscopy trainer |
Waschke, Kevin A. |
2016 |
48-49 | 3 |
p. 409-419 11 p. |
article |
|
| 254 | Treatment algorithms in Crohn's – Up, down or something else? |
Antunes, Ophélie |
2014 |
48-49 | 3 |
p. 473-483 11 p. |
article |
|
| 255 | Treatment of hepatitis B virus with combination therapy now and in the future |
Emery, Joel S. |
2017 |
48-49 | 3 |
p. 347-355 9 p. |
article |
|
| 256 | Use of somatostatin receptor ligands in obesity and diabetic complications |
Boehm, Bernhard O. |
2002 |
48-49 | 3 |
p. 493-509 17 p. |
article |
|
| 257 | Utility of non-endoscopic investigations in the practical management of oesophageal disorders |
Sifrim, Daniel |
2009 |
48-49 | 3 |
p. 369-386 18 p. |
article |
|
| 258 | Value of stigmata in decision-making in gastrointestinal haemorrhage |
Freeman, Martin L. |
2000 |
48-49 | 3 |
p. 411-425 15 p. |
article |
|
| 259 | Visceral sensitivity testing |
Andresen, Viola |
2009 |
48-49 | 3 |
p. 313-324 12 p. |
article |
|
| 260 | What is new on HBsAg and other diagnostic markers in HBV infection? |
Höner zu Siederdissen, Christoph |
2017 |
48-49 | 3 |
p. 281-289 9 p. |
article |
|
| 261 | What is the role of endoscopy and oesophageal biopsies in the management of GERD? |
Krugmann, Jens |
2013 |
48-49 | 3 |
p. 373-385 13 p. |
article |
|
| 262 | When can we cure Crohn's? |
Mantzaris, Gerassimos J. |
2014 |
48-49 | 3 |
p. 519-529 11 p. |
article |
262 results found